Placental matrix-derived mesenchymal stem cells (Z urology)

N/A

Report date: 2023/01/12 15:30:11

Base Information

Drug NamePlacental matrix-derived mesenchymal stem cells (Z urology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsErectile DysfunctionPenile Induration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUrocellz Rsrch
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUrocellz Rsrch
Active IndicationsN/A
Inactive IndicationsErectile DysfunctionPenile Induration

Other Information

ATC CodeN/A
Related LinksN/A